Canadian Journal of Addiction is a leading platform dedicated to advancing the understanding of addiction and its multifaceted impacts on individuals and society. Published by LIPPINCOTT WILLIAMS & WILKINS, this journal aims to foster rigorous research and discussion in the field of addiction studies, contributing significantly to the intersection of psychiatry and mental health. With its ISSN 2368-4720 and E-ISSN 2368-4739, the journal is indexed in Scopus and has been categorized in the Q3 quartile for 2023, reflecting its emerging influence amongst peers. The Canadian Journal of Addiction facilitates a vital exchange of ideas and findings, crucial for researchers, practitioners, and students alike, addressing pressing issues related to addiction through innovative studies and insightful reviews. Subscribers and readers benefit from the latest findings as they navigate through the dynamic landscape of addiction research, enriching both academic knowledge and practical applications.

CONTEMPORARY DRUG PROBLEMS is a distinguished academic journal published by SAGE PUBLICATIONS INC, focusing on critical issues within the realms of drug policy, health advocacy, and law. With a legacy dating back to its inception in 1973 and a noticeable convergence in subsequent years, the journal serves as a vital forum for researchers, practitioners, and policymakers engaged in understanding the multifaceted challenges related to drug use and its societal impacts. Holding an impressive Q2 ranking in both Health Policy and Health (social science), and a Q1 distinction in Law, the journal positions itself as an essential resource for advancing knowledge and fostering dialogue in these essential fields. Although it operates under traditional access models, its wide-ranging insights make it indispensable for those who aim to contribute meaningfully to the discourse surrounding contemporary drug issues. With its robust Scopus rankings, including a significant 89th percentile in Social Sciences Law, CONTEMPORARY DRUG PROBLEMS remains a pivotal source for scholars and professionals alike, striving to address and mitigate the complexities of drug-related problems on both a legal and social front.

Gaming Law Review: Economics Regulation Compliance and Policy is a groundbreaking journal published by Mary Ann Liebert, Inc., a renowned leader in disseminating cutting-edge research across various fields. Focused on the intersection of gaming, law, and economics, this journal delves into pressing issues regarding regulation, compliance, and policy surrounding the gaming industry. With an ISSN of 2572-5300 and E-ISSN 2572-5327, it serves as a crucial platform for academics, legal professionals, and policymakers to explore the dynamic landscape of gaming legislation and economic impact. While currently not open access, the journal allows for in-depth analysis and discussion necessary to navigate the complexities within this evolving field. With the rapid growth of the gaming sector, Gaming Law Review plays a vital role in contributing to an informed dialogue and providing researchers, professionals, and students access to pivotal insights and developments in gaming law and policy.

International Journal of Drug Policy, published by Elsevier, stands as a crucial scholarly platform dedicated to advancing the field of drug policy research. With an impactful focus on health policy and medicine, this journal holds a prestigious Q1 ranking in both Health Policy and Medicine (miscellaneous) categories as of 2023, reflecting its high-quality contributions to the discourse surrounding drug use, regulation, and public health. Spanning publication from 1998 to 2024, the journal's rich archive of research serves as an essential resource for researchers, professionals, and students alike. While the journal is not open access, it provides invaluable insights and significant findings that drive policy-making decisions and foster evidence-based practices in drug management and health interventions. With a Scopus rank of #28 out of 310 in Health Policy and #55 out of 398 in Medicine (miscellaneous), the International Journal of Drug Policy is indispensable for those committed to exploring and understanding the complexities of drug-related issues on a global scale.

The Journal of Studies on Alcohol and Drugs is a premier academic journal dedicated to advancing the understanding of alcohol and drug use, its effects, and its societal implications. Published by ALCOHOL RES DOCUMENTATION INC at the Center for Alcohol Studies, Rutgers University, this journal features comprehensive research that spans the disciplines of health, psychiatry, mental health, and toxicology. With its Q1 ranking in Health (Social Science) and Q2 ranking in Psychiatry and Mental Health, the journal plays a vital role in disseminating high-impact research that informs policy, prevention, and treatment strategies in addiction and substance use. The journal contributes significantly to the field, as evidenced by its solid Scopus rankings and engagement with contemporary issues, making it an essential resource for researchers, practitioners, and students. Although it does not offer open access, the journal's commitment to rigorous peer review and scholarship ensures that it remains at the forefront of research on alcohol and drugs through its converged publication timeline from 2007 to 2024.

Substance Abuse Treatment, Prevention, and Policy is a premier open access journal published by BMC, dedicated to advancing the understanding and improvement of substance abuse treatment and prevention strategies. Since its inception in 2006, this journal has established itself as a significant resource in the fields of Health Policy and Psychiatry and Mental Health, proudly maintaining a strong reputation reflected in its 2023 Scopus rankings, which place it in the top quartiles of these categories. With an impactful focus on policy implications and evidence-based practices, the journal's comprehensive coverage supports the sharing of innovative research and perspectives aimed at mitigating substance abuse challenges worldwide. Open access since its launch, it ensures that vital research is readily available to researchers, practitioners, and students alike, facilitating collaboration and discourse in this critical area of public health. Its commitment to high-quality research is underscored by its rankings within the 78th percentile for Health Policy and 66th percentile for Psychiatry and Mental Health, highlighting its influence and relevance in addressing pressing issues in substance misuse.

ADDICTION, published by Wiley, is a highly regarded academic journal that serves the vibrant fields of Medicine and Psychiatry and Mental Health. With an impressive impact factor reflective of its significance—ranking in the top 8% and 7.5% of its categories respectively—this journal is esteemed for its rigorous peer-reviewed research which spans a wide array of topics related to addiction, including pharmacology, prevention, and treatment modalities. Since its inception in 1993, ADDICTION has continually provided a platform for innovative research, shaping the discourse and influencing clinical practices worldwide. This journal, based in the United Kingdom at a prestigious location in Hoboken, NJ, stands as a beacon for researchers, practitioners, and students alike, committed to advancing understanding and strategies to combat addiction-related challenges. Although it is not an Open Access publication, the journal's contribution to the field remains invaluable, ensuring that cutting-edge findings are disseminated widely among professionals dedicated to improving mental health outcomes.

The International Journal of Prisoner Health, with ISSN 1744-9200 and E-ISSN 1744-9219, is a leading academic publication by EMERALD GROUP PUBLISHING LTD, dedicated to exploring the intersection of health and incarceration. Since its inception in 2005, this journal has played a pivotal role in addressing the health needs of imprisoned populations, providing a platform for innovative research and critical discourse within the field. With an impressive Scopus ranking in the 82nd percentile and categorized as Q2 in Health Professions and Q3 in Medicine for 2023, it is a vital resource for academics, healthcare professionals, and social scientists alike. The journal emphasizes the importance of improving health outcomes in correctional settings, shedding light on the unique challenges faced by this vulnerable demographic. While the journal is not currently open access, its valuable insights remain essential for those striving for equity in health care delivery. Readers are encouraged to engage with the latest findings and contribute to this significant area of study.

The JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION, published by Elsevier, serves as a pivotal resource for professionals and researchers in the field of pharmacology and pharmacy. With an impressive 2023 impact factor and classification in the top quartiles (Q1 and Q2) of pharmacology and nursing, this journal is recognized for its high-quality research and contributions that shape contemporary pharmaceutical practices. This journal addresses a broad spectrum of topics within the pharmaceutical sciences, offering insights into the latest advancements in medication management, patient care, and health policy. As a trusted platform for disseminating knowledge, it aims to enhance the professional development of pharmacists and pharmacy practitioners. By maintaining rigorous peer-review standards and a commitment to the dissemination of innovative research, the journal plays a crucial role in advancing the field of pharmacy and improving health outcomes on a global scale.

Journal of Substance Use & Addiction Treatment is a premier scholarly publication dedicated to advancing the understanding and treatment of substance use disorders and addictive behaviors. Published by Elsevier Science Inc, this journal serves as a vital platform for researchers, clinicians, and students in the fields of psychology, psychiatry, public health, and addiction studies. With its commitment to Open Access, the journal facilitates wide dissemination of cutting-edge research, enabling practitioners and policymakers to access critical findings that inform treatment approaches and public health strategies. As an essential resource in addiction treatment and research, the Journal of Substance Use & Addiction Treatment aims to foster interdisciplinary collaboration and innovation, ultimately improving outcomes for individuals affected by addiction.